Free Trial

Ontario Teachers Pension Plan Board Has $2.04 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

HCA Healthcare logo with Medical background

Ontario Teachers Pension Plan Board cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 65.7% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,026 shares of the company's stock after selling 9,628 shares during the period. Ontario Teachers Pension Plan Board's holdings in HCA Healthcare were worth $2,043,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $231,000. Bessemer Group Inc. raised its stake in shares of HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company's stock valued at $2,543,000 after acquiring an additional 2,584 shares during the period. Swedbank AB acquired a new stake in HCA Healthcare in the 1st quarter valued at $95,882,000. EP Wealth Advisors LLC lifted its stake in shares of HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company's stock worth $72,335,000 after purchasing an additional 3,516 shares in the last quarter. Finally, AustralianSuper Pty Ltd grew its stake in shares of HCA Healthcare by 118.5% in the third quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company's stock valued at $14,425,000 after buying an additional 19,247 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Insiders Place Their Bets

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,155 shares of company stock worth $5,608,990. 1.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have issued reports on HCA. StockNews.com downgraded shares of HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an "equal weight" rating in a report on Wednesday, November 6th. Oppenheimer boosted their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research note on Monday, October 28th. Royal Bank of Canada increased their target price on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research note on Friday, August 23rd. Finally, Morgan Stanley assumed coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 price target on the stock. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $385.00.

Check Out Our Latest Research Report on HCA

HCA Healthcare Stock Performance

Shares of HCA traded down $2.11 during midday trading on Wednesday, hitting $333.00. 1,426,476 shares of the stock traded hands, compared to its average volume of 1,189,091. The firm has a market capitalization of $84.35 billion, a PE ratio of 15.05, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68. The business's 50 day moving average price is $383.10 and its two-hundred day moving average price is $358.30. HCA Healthcare, Inc. has a 1-year low of $245.84 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is 11.85%.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Should you invest $1,000 in HCA Healthcare right now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines